SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-316526
Filing Date
2019-12-18
Accepted
2019-12-17 21:09:11
Documents
15
Period of Report
2019-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d835112d8k.htm   iXBRL 8-K 34413
2 EX-99.1 d835112dex991.htm EX-99.1 9001
3 EX-99.2 d835112dex992.htm EX-99.2 9667
7 GRAPHIC g835112g42w00.jpg GRAPHIC 18290
  Complete submission text file 0001193125-19-316526.txt   205177

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20191217.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20191217_lab.xml EX-101.LAB 18084
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20191217_pre.xml EX-101.PRE 11375
17 EXTRACTED XBRL INSTANCE DOCUMENT d835112d8k_htm.xml XML 3451
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 191291147
SIC: 2834 Pharmaceutical Preparations